Worldwide Healthcare Trust PLC GBP (GB:WWH)
LSE:WWH
Want to see GB:WWH full AI Analyst Report?
WWH Stock Chart & Stats
376.00 p
0.00 p(0.00%)
At close: 4:00 PM EST
376.00 p
0.00 p(0.00%)
Day’s Range― - ―
52-Week Range294.50 p - 397.03 p
Previous CloseN/A
Volume99.78K
Average Volume (3M)1.52M
Market Cap
£1.29B
Enterprise Value1.22B
Total Cash (Recent Filing)£70.82M
Total Debt (Recent Filing)£18.88M
Price to Earnings (P/E)12.6
Beta0.81
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.63%
Share Statistics
EPS (TTM)0.27
Shares Outstanding362,088,780
10 Day Avg. Volume1,353,432
30 Day Avg. Volume1,519,410
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)1.02
Price to Sales (P/S)113.12
P/FCF Ratio-1.83K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a sizeable equity cushion improve the trust's resilience to market drawdowns and reduce the risk of forced selling. For a closed-end, conservatively positioned balance sheet supports the ability to hold volatile healthcare positions through cycles and preserve long-term capital.
Sector-focused, Diversified MandateA focused healthcare mandate combined with diversification across subsectors gives thematic exposure to durable structural demand (aging populations, innovation). This reduces single-stock risk while allowing managers to leverage sector expertise to capture long-term growth opportunities.
Ability To Capture Sizable Portfolio GainsEpisodes of meaningful net gains demonstrate the trust's capacity to realize capital appreciation from portfolio selection. This shows the manager can identify high-return opportunities, an important durable driver of long-term NAV growth if process and access to ideas remain intact.
Bears Say
Weak, Inconsistent Cash GenerationPersistent weak and erratic cash flow limits internal funding for fees or distributions and raises reliance on portfolio disposals. For an investment trust, poor cash conversion constrains flexibility to manage liquidity and increases vulnerability when market opportunities to realize gains are limited.
Highly Volatile Earnings And RevenueMarked swings in earnings and revenue reduce predictability of returns and complicate compounding for shareholders. Volatility suggests sensitivity to market timing and valuation moves, limiting confidence that recent profitable years indicate a stable trend rather than episodic gains.
Profitability Often Non‑cash In NatureWhen reported profits rely on unrealized valuation gains rather than cash receipts, the quality of earnings is lower. This elevates risk that NAV gains may reverse, forcing realizations or impairing future distributable resources during downturns and stressing long-term stability.
Worldwide Healthcare Trust PLC GBP News
WWH FAQ
What was Worldwide Healthcare Trust PLC GBP’s price range in the past 12 months?
Worldwide Healthcare Trust PLC GBP lowest share price was 294.50 p and its highest was 397.03 p in the past 12 months.
What is Worldwide Healthcare Trust PLC GBP’s market cap?
Worldwide Healthcare Trust PLC GBP’s market cap is £1.29B.
When is Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date?
Worldwide Healthcare Trust PLC GBP’s upcoming earnings report date is Nov 18, 2026 which is in 150 days.
How were Worldwide Healthcare Trust PLC GBP’s earnings last quarter?
Worldwide Healthcare Trust PLC GBP released its earnings results on Jun 05, 2026. The company reported 0.165 p earnings per share for the quarter, beating the consensus estimate of N/A by 0.165 p.
Is Worldwide Healthcare Trust PLC GBP overvalued?
According to Wall Street analysts Worldwide Healthcare Trust PLC GBP’s price is currently Overvalued.
Does Worldwide Healthcare Trust PLC GBP pay dividends?
Worldwide Healthcare Trust PLC GBP pays a Semiannually dividend of 1.7 p which represents an annual dividend yield of 0.63%. See more information on Worldwide Healthcare Trust PLC GBP dividends here
What is Worldwide Healthcare Trust PLC GBP’s EPS estimate?
Worldwide Healthcare Trust PLC GBP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Worldwide Healthcare Trust PLC GBP have?
Worldwide Healthcare Trust PLC GBP has 362,088,780 shares outstanding.
What happened to Worldwide Healthcare Trust PLC GBP’s price movement after its last earnings report?
Worldwide Healthcare Trust PLC GBP reported an EPS of 0.165 p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.023%.
Which hedge fund is a major shareholder of Worldwide Healthcare Trust PLC GBP?
Currently, no hedge funds are holding shares in GB:WWH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Worldwide Healthcare Trust PLC GBP
Worldwide Healthcare Trust PLC (WWH.L) operates as a closed-ended equity investment fund, established by Frostrow Capital LLP. OrbiMed Capital LLC is responsible for managing its investments, which span public stock markets across the globe. Specifically, it targets companies within the healthcare industry, giving particular attention to pharmaceutical and biotechnology firms. The trust primarily allocates capital to growth-oriented large-capitalization companies, specifically those with a market value of at least $5 billion. Portfolio construction is guided by fundamental analysis and a bottom-up stock selection methodology, with investment decisions supported by proprietary internal research. Its performance is measured against the MSCI World Healthcare Index. Established in April 1995 and domiciled in the United Kingdom, it was previously known as Finsbury Worldwide Pharmaceutical Trust plc.